Results 101 to 110 of about 18,985 (204)
, 2017 Muhammad Omer Jamil, Mary S Jerome, Deborah Miley, Katri S Selander, Francisco Robert Division of Hematology and Oncology, Department of Medicine, Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA ...
Jamil MO +4 more
core
Zoledrinic Acid Induces Steoblastic Differentiation of Mesenchymal Stem Cells without Change in Hypomethylation Status of OSTERIX Promoter [PDF]
Cell Journal, 2012 Objective: Mechanism of zoledronic acid on osteoblastic differentiation of mesenchymal stem cells (MSCs) has not fully understood. With the knowledge of some drugs mechanism that alter methylation pattern of some genes, the present research sets out to ...
Maryam Mahmodinia Maymand +5 more
doaj
, 2012 Akshara Richhariya1, Yi Qian2, Yufan Zhao2, Karen Chung11Amgen Inc, Global Health Economics, Thousand Oaks, CA, USA; 2Amgen Inc, Global Biostatistical Sciences, Thousand Oaks, CA, USAPurpose: Intravenous (IV) zoledronic acid (ZA) is commonly used to ...
Richhariya A, Qian Y, Chung K, Zhao Y
core
Zoledronic acid in the management of metastatic bone disease
Therapeutics and Clinical Risk Management, 2008 Thomas J Polascik, Vladimir MouravievDuke Prostate Center and Division of Urologic Surgery, Duke University Medical Center, Durham, NC, USAAbstract: Many patients with advanced cancer experience decreased bone strength due to metastatic foci, underlying ...
Thomas J Polascik, Vladimir Mouraviev
doaj
, 2010 Johann D RingeDirektor der Med. Klinik 4, Allgemeine Innere, und Westdeutsches Osteoporose Zentrum (WOZ), Klinikum Leverkusen gGmbH, Leverkusen, GermanyAbstract: Osteoporosis is a major health concern, which results in the increased risk of fractures ...
Johann D Ringe
core
Muhammet Bahattin Bingul,1 Mehmet Gul,2 Serkan Dundar,3 Alihan Bozoglan,3 Mustafa Kirtay,4 Muhammet Fatih Ozupek,5 Erhan Cahit Ozcan,6 Osman Habek,1 Ismail Tasdemir7 1Department of Oral and Maxillofacial Surgery, Harran University, Faculty of Dentistry ...
Tasdemir I +8 more
core
Effect of Zoledronic Acid on Rats' Tissue Sdf-1 Expression
, 2016 Zoledronic acid has been shown to inhibit cancer cell proliferation, metastasis and induce cancer cell apoptosis. Stromal Derived Factor-1 (SDF-1) is a chemokine that has been reported to be expressed markedly high in the most common metastatic sites ...
Arik, Zafer +6 more
core +1 more source
, 2011 Allan LiptonMilton S. Hershey Medical Center, Pennsylvania State University, Hershey, PA, USAAbstract: Bisphosphonates inhibit osteoclast-mediated bone resorption, thereby inhibiting the release of growth factors necessary to promote cancer cell growth ...
Allan Lipton
core
A case report: zoledronic acid-induced anterior uveitis
, 2008 Background Bisphosphonates prevent bone loss by binding on active sites of bone remodeling and inhibiting osteoclast-mediated bone resorption. Zoledronic acid is recommended for patients with bone metastases from breast, prostate, and lung cancers ...
ALTUNDAĞ, MUSTAFA KADRİ +3 more
core +1 more source